Direct effects on human cardiomyocytes by cancer therapy with monoclonal antibodies to HER2/erbB2 are not related to apoptosis

被引：0
|
作者：
Zuppinger, C
Immer, F
Sawyer, DB
Suter, TM
机构：
[1] Univ Hosp, Dept Heart & Vessels, Bern, Switzerland
[2] Boston Univ, Sch Med, Cardiovasc Med Sect, Boston, MA 02118 USA
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
456
引用
收藏
页码：97 / 98
页数：2
相关论文
共 50 条
  • [41] Dual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu)
    Reid, Alison
    Vidal, Laura
    Shaw, Heather
    de Bono, Johann
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (03) : 481 - 489
  • [42] The HER2/neu (erbB2) polymorphism, body mass index, and the risk of endometrial cancer
    Lee, J.
    Tong, S.
    Lee, K.
    Kim, J.
    Kwon, Y.
    Kim, J.
    Kim, Y.
    Yei, J.
    Do, Y.
    Kwon, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells
    Marcus, Elizabeth A.
    Tokhtaeva, Elmira
    Turdikulova, Shahlo
    Capri, Joseph
    Whitelegge, Julian P.
    Scott, David R.
    Sachs, George
    Berditchevski, Fedor
    Vagin, Olga
    BIOCHEMICAL JOURNAL, 2016, 473 : 1703 - 1718
  • [44] HER2 and immunotherapy using monoclonal antibodies in colorectal cancer
    Mojarad, Ehsan Nazemalhosseini
    Kuppen, Peter J. K.
    IMMUNOTHERAPY, 2013, 5 (12) : 1267 - 1269
  • [45] RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
    Singh, Harshabad
    Sahgal, Pranshu
    Kapner, Kevin
    Corsello, Steven M.
    Gupta, Hersh
    Gujrathi, Rahul
    Li, Yvonne Y.
    Cherniack, Andrew D.
    El Alam, Raquelle
    Kerfoot, Joseph
    Andrews, Elizabeth
    Lee, Annette
    Nambiar, Chetan
    Hannigan, Alison M.
    Remland, Joshua
    Brais, Lauren
    Leahy, Meghan E.
    Rubinson, Douglas A.
    Schlechter, Benjamin L.
    Meyerson, Matthew
    Kuang, Yanan
    Paweletz, Cloud P.
    Lee, Jessica K.
    Quintanilha, Julia C. F.
    Aguirre, Andrew J.
    Perez, Kimberly J.
    Huffman, Brandon M.
    Rossi, Humberto
    Abrams, Thomas A.
    Kabraji, Sheheryar
    Trusolino, Livio
    Bertotti, Andrea
    Sicinska, Ewa T.
    Parikh, Aparna R.
    Wolpin, Brian M.
    Schrock, Alexa B.
    Giannakis, Marios
    Ng, Kimmie
    Meyerhardt, Jeffrey A.
    Hornick, Jason L.
    Sethi, Nilay S.
    Cleary, James M.
    CLINICAL CANCER RESEARCH, 2024, 30 (08) : 1669 - 1684
  • [46] Targeting HER2 in Colorectal Cancer: The Landscape of Amplification and Short Variant Mutations in ERBB2 and ERBB3
    Ross, Jeffrey S.
    Fakih, Marwan
    Ali, Siraj M.
    Elvin, Julia A.
    Schrock, Alexa B.
    Suh, James
    Vergilio, Jo-Anne
    Ramkissoon, Shakti
    Severson, Eric
    Daniel, Sugganth
    Fabrizio, David
    Frampton, Garrett
    Sun, James
    Miller, Vincent A.
    Stephens, Philip J.
    Gay, Laurie M.
    CANCER, 2018, 124 (07) : 1358 - 1373
  • [47] Exploration of HER2 (ERBB2) immunohistochemistry in non-small cell lung cancer: correlation with ERBB2 mutational status: experimental research
    Cardillo, Anthony B.
    Kovar, Sierra
    Roper, Nitin
    Hicks, David G.
    Velez, Moises J.
    ANNALS OF MEDICINE AND SURGERY, 2023, 85 (06): : 2640 - 2646
  • [48] ERBB2 (HER2) Gene Amplification and Protein Overexpression in Ampullary Carcinoma
    Hechtman, Jaclyn
    Arcila, Maria
    Vakiani, Efsevia
    Shia, Jinru
    Klimstra, David
    MODERN PATHOLOGY, 2015, 28 : 165A - 165A
  • [49] HER2/ERBB2 Testing in Breast Carcinoma by Next Generation Sequencing
    Wong, Adele
    Bhan, Atul
    Lennerz, Jochen K.
    Brachtel, Elena
    MODERN PATHOLOGY, 2017, 30 : 522A - 522A
  • [50] ErbB2/HER2/Neu resembles an autoinhibited invertebrate EGF receptor
    Alvarado, Diego
    Klein, Daryl E.
    Lemmon, Mark A.
    FASEB JOURNAL, 2009, 23
12345